Search Results
Site Search
Whole genome sequencing - Insights
Check out Mayo Clinic Laboratories’ whole genome testing, a next-generation sequencing assay that interrogates nearly every base pair of an individual’s DNA, including the mitochondrial genome.
Pediatric CNS Disorder Testing - Mayo Clinic Laboratories
We offer a first-of-its-kind profile including only the antibodies that are pertinent to pediatric CNS disorders—all in one evaluation.
Learn how our renal genetic testing was developed by a team of experts and is among the most comprehensive diagnostic testing available.
November 2023 - Clinical Informatics - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Clinical Informatics.
Carbohydrate metabolism - Insights
Learn more about how Mayo Clinic Laboratories testing for carbohydrate metabolism can identify genetic variants and confirm diagnosis of these complex conditions.
Inborn errors of metabolism - Insights
Learn more about how Mayo Clinic Laboratories’ comprehensive menu of biochemical and molecular testing can diagnose inborn errors of metabolism.
Malabsorption panel: Filling a gap in pediatric care - Insights
Mayo Clinic Laboratories is committed to innovation that provides the right test at the right time for the right patients. That effort always starts with identifying gaps in patient care. Filling those gaps sometimes involves not developing...
Precision oncology therapeutics - Insights
Learn more about our personalized cancer testing that establishes patients’ genetic profiles and allows physicians to select medications that optimize therapeutic efficacy while minimizing harmful reactions.
Leading pathology's technology transformation - Insights
As chair of Mayo Clinic’s new Division of Computational Pathology and AI in the Department of Laboratory Medicine and Pathology, Jason Hipp, M.D., Ph.D., is eager to employ the most innovative tools available to benefit patients around the...
At BioPharma Diagnostics, we are inspired by Mayo Clinic’s history of collaboration and breaking down barriers to change medicine. That’s why we bring Mayo Clinic expertise and quality to each project — from consulting through discovery to...
Biologic Therapy Testing - Mayo Clinic Laboratories
To monitor for immunogenicity, our reflexive approach first measures the biologic concentration within a patient’s specimen. Then, if necessary, an additional test is performed to assess the presence of antibodies to a specific drug that...
Precision transplant therapeutics - Insights
We offer a precision-driven solution to transplant therapeutics that combines pharmacogenomics, therapeutic drug monitoring, expert clinical support, and decades of leadership and research.
New tests launched in June - Insights
In June 2023, Mayo Clinic Laboratories announced 28 new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
A new comprehensive genetic panel redefines Parkinson's disease diagnosis - Insights
Mayo Clinic Laboratories introduces the Inherited Parkinson’s Disease Gene Panel (Mayo ID: PARDP), a collaborative breakthrough poised to transform Parkinson’s disease diagnosis and treatment. Led by Rodolfo Savica, M.D., Ph.D., and Zhiyv...
Autoimmune Encephalopathy Testing - Mayo Clinic Laboratories
Our phenotype specific testing for autoimmune encephalopathy contains only clinically relevant antibodies providing accurate answers for treatment guidance.
Selecting Pathology Specimens for Solid Tumors Next-Generation Sequencing - Insights
In this month’s “Hot Topic,” Sounak Gupta, M.B.B.S., Ph.D., discusses selecting tissues and other tissue considerations for molecular testing. He also reviews tissue metrics and requirements, which differ based on test platforms. It is...
The exchange of medical knowledge is a founding principle of Mayo Clinic. William J. Mayo, M.D., said it best: “It is a great thing to make scientific discoveries of rare value, but it is even greater to be willing to share these...
Myeloproliferative neoplasms - Insights
Learn about our reflexive molecular testing protocols that are designed to guide proper utilization of myeloproliferative neoplasms.
IDH assay facilitates timelier leukemia treatment: Rong He, M.D. - Insights
In this test-specific episode of the "Answers From the Lab" podcast, Rong He, M.D., explains how Mayo Clinic Laboratories' IDHQ test improves upon next generation sequencing for assessing AML treatment options.
Frequently asked questions - Insights
Check out the answers to the most frequently asked questions about pharmacogenomic testing at Mayo Clinic Laboratories.
Linda Hasadsri, M.D., Ph.D., explains carrier screening at Mayo Clinic Laboratories. Using targeted genotyping, our three focused panels evaluate genes associated with cystic fibrosis, spinal muscular atrophy, and hemoglobinopathies, to...
A journey to diagnosis: One patient's story of resilience and hope - Insights
For many, the path to a correct diagnosis can be long and filled with uncertainty. This story highlights the resilience and determination of one patient who navigated a complex medical journey to find answers and hope at Mayo Clinic. The...
Mucopolysaccharidosis type I (MPS I) is a rare genetic disorder that typically presents with progressive multisystem involvement in early childhood. This condition results from the deficiency of the enzyme, alpha-L-iduronidase (IDUA), which...
New tests launched in January - Insights
In January 2022, Mayo Clinic Laboratories announced twenty five new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Controlled substance monitoring - Insights
The Clinical and Forensic Toxicology Laboratory at Mayo Clinic offers the industry’s most comprehensive evidence-based urine drug testing menu to evaluate for the presence of controlled substances.
Detecting danger: Dan O'Bryan - Insights
Dan O’Bryan didn’t think his dizziness and lightheadedness were anything to worry about. Nearly 100 miles away, the team at Mayo Clinic that was remotely monitoring Dan’s heart could see the truth.
Next-generation sequencing - Insights
Browse our full menu of genetic testing, which provides the highest quality molecular assays available.
In this month's "Hot Topic," Paul Jannetto, Ph.D., identifies how to determine new vs. residual use of marijuana in a patient, and teaches how to calculate the carboxy-tetrahydrocannabinol (carboxy-THC) to creatinine ratio along with a...
Infectious Diseases - Insights
Learn how our clinical microbiology laboratory can aid in diagnosing pediatric illnesses caused by insects, fungal species, and parasites.
Join us at the American Academy of Neurology Annual Meeting to learn about the latest in autoimmune and genetic neurology testing.
Autoimmune Epilepsy Testing - Mayo Clinic Laboratories
Our phenotype specific testing for autoimmune epilepsy contains only clinically relevant antibodies providing accurate answers for treatment guidance.
Discover cutting-edge movement disorder diagnostics at Mayo Clinic Laboratories, encompassing autoimmune and hereditary conditions.
A simpler path to answers for patients with mast cell activation syndrome - Insights
A random urine test panel aids in diagnosing mast cell activation syndrome (MCAS), a complex condition often misdiagnosed due to overlapping symptoms. The panel improves access, speeds up diagnosis, and enables individualized treatment by...
Biopharma only testing - Insights
Find out how our suite of BioPharma Diagnostics-specific neurology testing can provide answers for your patients.
Browse our full menu of individual tests and panels that aid in the diagnosis of tick-borne diseases.
New tests launched in August - Insights
In August 2022, Mayo Clinic Laboratories announced thirty-two new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
One of the biggest misunderstandings about genetic testing is a perception that once a variant is identified and analyzed thoroughly, using all the best tools available, it can be associated with a specific disease or condition. But many...
https://www.mayocliniclabs.com/test-notifications/cpt-codes.php?format=excel
cpt_code_updates Mayo Test ID Test Name CPT Code GLSF Glucose, Spinal Fluid 82945 A1AF Alpha-1-Antitrypsin, Random, Feces 82103 TPSF Protein, Total, Spinal Fluid 84157 HCO3 Bicarbonate, Serum 82374 TIBC Total Iron Binding Capacity,...
UofL Health – UofL Hospital physicians and laboratory scientists faced challenges in the ordering of autoimmune and paraneoplastic panels: duplicate orders that add unnecessary cost and omitted test orders that could provide the key to the...
New tests launched in March - Insights
In March 2023, Mayo Clinic Laboratories announced twenty nine new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
The Living Breast Biobank - Insights
This unique Mayo Clinic resource offers a novel portal into the study of gene mutations before they cause breast cancer.
An order-entry, clinical decision support tool developed by physicians and scientists at Froedtert and the Medical College of Wisconsin (MCW) for clinicians within the healthcare system who order autoimmune and paraneoplastic antibody...
Infectious diseases - Insights
Mayo Clinic offers a broad selection of tests designed for rapid identification and in-depth characterization of the causative agents of infectious diseases.
Whole exome sequencing - Insights
Learn more about how whole exome sequencing at Mayo Clinic Laboratories can quickly end diagnostic testing odysseys for patients with suspected genetic disorders.
Frequently asked questions - Insights
Read answers to frequently asked questions about prenatal testing at Mayo Clinic Laboratories, including specimen requirements, maternal cell contamination testing, pricing, and more.
Laboratory Testing of Bone Turnover Markers - Insights
In this “Hot Topic,” Alicia Algeciras-Schimnich, Ph.D., professor of laboratory medicine and pathology at Mayo Clinic, discusses the role of bone turnover markers in osteoporosis treatment as well as how to best interpret changes in bone...
Mayo Clinic Laboratories’ comprehensive dementia testing menu includes evaluations for Alzheimer's disease, autoimmune dementia, and rapidly progressive dementia.
Medical Drones: High Hopes, Grounded in Science - Insights
While online retailers experiment with drones as a way to swiftly deliver consumer purchases, laboratory medicine physicians and scientists have a lifesaving goal: using drones to rapidly deliver laboratory specimens.
Focused lung panel informs the use of targeted cancer therapies - Insights
Ying-Chun Lo, M.D., Ph.D., explains how Mayo Clinic Laboratories' updated lung panel can better guide clinical decision-making, particularly about targeted lung cancer therapies.
The exponential increase in the number of diagnostic tests available to physicians (in dermatopathology as well as other medical specialties) can be overwhelming, according to a new multi-institutional study co-published in the Journal of...